Cargando…
Palmar-plantar erythrodysesthesia: An uncommon adverse effect of everolimus
Mammalian target of rapamycin inhibitor everolimus is a novel agent used in endocrine therapy resistant hormone receptor positive metastatic breast cancer. Its use has been associated with clinically significant improvement in the otherwise dismal outcomes of this subset of patients. Rash is a commo...
Autores principales: | Arora, Shalabh, Akhil, Rajendra, Chacko, Raju Titus, George, Renu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4854043/ https://www.ncbi.nlm.nih.gov/pubmed/27168711 http://dx.doi.org/10.4103/0971-5851.180143 |
Ejemplares similares
-
Paclitaxel-Induced Palmar-Plantar Erythrodysesthesia
por: Wahab, Ahsan, et al.
Publicado: (2020) -
Docetaxel induced severe palmar plantar erythrodysesthesia
por: Kharmoum, Saoussane, et al.
Publicado: (2018) -
Palmar-plantar erythrodysesthesia secondary to docetaxel chemotherapy: a case report
por: Benghiat, Helen, et al.
Publicado: (2011) -
Palmar-plantar erythrodysesthesia associated with capecitabine chemotherapy: a case report
por: Kigen, Gabriel, et al.
Publicado: (2015) -
Palmar-Plantar Erythrodysesthesia Associated with Chemotherapy and Its Treatment
por: Farr, Katherina Podlekareva, et al.
Publicado: (2011)